source
- Cambridge biologist David Sabatini awarded $6 million after jury rejects harassment claimsDavid Sabatini, a former MIT and Whitehead Institute researcher, faced allegations of inappropriate conduct from a younger colleague, leading to his removal from the institute. A Suffolk County ju…
- As AbbVie’s Crohn’s combo beats Skyrizi in mid-stage test, analysts laud autoimmune visionAbbVie’s next-gen dual-targeting therapy elicited higher rates of remission than its IL-23 inhibitor Skyrizi in a Phase 2a trial of Crohn’s disease, leading analysts to wonder if the blockbuster ca…BioSpace · 1d ago↗ source
- AbbVie’s Skyrizi combo beats Skyrizi alone in mid-stage Crohn’s trial